People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Redona Therapeutics, Inc. | — | Biotechnology | Series C | $66.8M | $76.2M | 2018 |
| Nitrome Biosciences, Inc | — | Biotechnology | Series B | $18.9M | $680.1M | 2020 |
Henrijette Richter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Henrijette Richter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Luke Evnin | 1 | 12 |
| Briggs Morrison | 1 | 8 |
| Michal Silverberg | 1 | 7 |
| Kazumi Shiosaki | 1 | 4 |
| Marian Nakada | 1 | 4 |
| Margarita Chavez | 1 | 4 |
| Jonathan Behr | 1 | 4 |
| Christine Brennan | 1 | 3 |
| Carolyn Ng | 1 | 2 |
| Ephraim Heller | 1 | 2 |
| Zach Hall | 1 | 1 |
| William McDowell | 1 | 1 |
| Regis Kelly | 1 | 1 |
| Regis W. Kelly | 1 | 1 |
| Zach W. Hall | 1 | 1 |
| William W. McDowell | 1 | 1 |
| Ephreim Heller | 1 | 1 |
| Irene Griswold-Prenner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.